TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Digestive System Department
Division of General Internal Medicine
更新時間：2023-09-19
劉志銘LIOU, JYH-MING
- Co-Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
jyhmingliou@gmail.com
Publication
28Publications
21
Chen MJ, Chen CC, Huang YC, Tseng CC, Hsu JT, Lin YF, Fang YJ, Wu MS, Liou JM; Taiwan Gastrointestinal Disease, Helicobacter Consortium. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial. Helicobacter. 2021 Dec;26(6):e12857. doi: 10.1111/hel.12857. Epub 2021 Oct 27.
22
Liou JM, Chen PY, Luo JC, Lee JY, Chen CC, Fang YJ, Yang TH, Chang CY, Bair MJ, Chen MJ, Hsu YC, Hsu WF, Chang CC, Lin JT, Shun CT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. Gastroenterology. 2018 Oct;155(4):1109-1119. doi: 10.1053/j.gastro.2018.06.047. Epub 2018 Jun 30. PMID: 29964036.
23
Kuo YT*, Liou JM*, El-Omar EM, Wu JY, Leow AHR, Goh KL, Rajashree D, Lu H, Lin JT, Tu YK, Yamaoka Y, Wu MS, The Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM). Trends in Primary Antibiotic Resistance of Helicobacter pylori in Asia-Pacific region: A Systematic Review and Meta-analysis. Lancet Gastroenterol Hepatol 2017;2(10):707-715.
24
Liou JM, Fang YJ, Chen CC, et al. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori - a multicentre randomised trial. Lancet 2016;388:2355-65
25
Liou JM, Chen CC, Chang CY, et al. Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial. Gut 2016;65:1784-92.
26
Liou JM, Bair MJ, Chen CC, et al. Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial. Am J Gastroenterol. 2016;111:381-7.
27
Liou JM, Chen CC, Chen MJ, et al. Sequential s versus triple therapy in the first line treatment of Helicobacter pylori -A multicenter, open label, randomised trial. Lancet 2013;381:205-13.
28
Liou JM, Lin JT, Chang CY, et al. Levofloxacin-based and Clarithromycin-based Triple Therapies in the First Line and Second Line Treatments for Helicobacter pylori Infection- A Randomized Comparative Trial with Cross Over Design. Gut 2010; 59:572-8.
